Shunji Endo

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Long-term Outcomes of OGSG1108: A Supplemental Study of Oral Nutritional Supplementation During Adjuvant S-1 Chemotherapy.

Long-term Outcomes of OGSG1108: A Supplemental Study of Oral Nutritional Supplementation During Adjuvant S-1 Chemotherapy.

Journal: Anticancer research

Published: May 07, 2026

Complete Response of Adrenal Metastasis from Pancreatic Cancer Achieved by Multimodal Therapy-A Case Report

Complete Response of Adrenal Metastasis from Pancreatic Cancer Achieved by Multimodal Therapy-A Case Report

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Short-Term Outcomes of Laparoscopic Surgery for Colorectal Cancer in Super-Elderly Patients Aged 90 and Over at Our Institution Pancreatic Body Cancer

Short-Term Outcomes of Laparoscopic Surgery for Colorectal Cancer in Super-Elderly Patients Aged 90 and Over at Our Institution Pancreatic Body Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Rare Case of Appendiceal Gastrointestinal Stromal Tumor: Diagnosis, Surgical Management, and Long-term Outcome.

Rare Case of Appendiceal Gastrointestinal Stromal Tumor: Diagnosis, Surgical Management, and Long-term Outcome.

Journal: Cancer diagnosis & prognosis

Published: December 24, 2025

Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701.

Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: December 12, 2025

Effect of perioperative nutritional status, inflammatory response and postoperative chemotherapy on survival after gastrectomy for advanced gastric cancer.

Effect of perioperative nutritional status, inflammatory response and postoperative chemotherapy on survival after gastrectomy for advanced gastric cancer.

Journal: Oncology letters

Published: December 10, 2025

Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting.

Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting.

Journal: Asian journal of endoscopic surgery

Published: November 18, 2025

Management of Median Arcuate Ligament Compression in Patients Undergoing Pancreaticoduodenectomy: A Systematic Review and Consensus Statements.

Management of Median Arcuate Ligament Compression in Patients Undergoing Pancreaticoduodenectomy: A Systematic Review and Consensus Statements.

Journal: Asian journal of endoscopic surgery

Published: November 17, 2025

Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome.

Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome.

Journal: Asian journal of endoscopic surgery

Published: November 10, 2025

ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancer.

ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancer.

Journal: Future oncology (London, England)

Published: October 21, 2025

Hemophagocytic syndrome caused by Epstein-Barr virus and cytomegalovirus infection during neoadjuvant chemoradiotherapy for rectal cancer: a case report.

Hemophagocytic syndrome caused by Epstein-Barr virus and cytomegalovirus infection during neoadjuvant chemoradiotherapy for rectal cancer: a case report.

Journal: Frontiers in medicine

Published: October 14, 2025

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: October 13, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026